Conference Call with Divi's Laboratories Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript.
Pharmaceuticals firm Divi's Laboratories announced Q3FY23 results: Consolidated Q3FY23 & 9MFY23: Divi’s Laboratories has earned a consolidated total income of Rs 1,822 crores for Q3FY23 as against a total income of Rs 2,510 crores during the corresponding quarter of last year. Profit before Tax (PBT) for Q3FY23 accounted to Rs 436 crores, as against a PBT of Rs 1,034 crores during the corresponding quarter of last year. Profit after Tax (PAT) for the current is Rs 307 crores as against a PAT of Rs 902 crores for the corresponding quarter of last year. For the 9MFY23, the company earned a PAT of Rs 1,502 crores on a total income of Rs 6,099 crores, as against a PAT of Rs 2,066 crores on a total income of Rs 6,503 crores during the corresponding previous period. Result PDF